Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Metozolv ODT, metoclopramide (formerly Zydis)
print preview
bookmark
share with colleague
General Information
Company
Salix Pharmaceuticals Inc.
Description
Orally disintegrating tablet formulation of metoclopramide
Molecular Target
Dopamine receptor
Mechanism of Action
Dopamine receptor antagonist
Latest Stage of Development
Marketed
Indication
Gastroesophageal reflux disease (GERD)
Partner
Wilmington Pharmaceuticals
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy